|
|  Get related patents on CD |
| United States Patent | 4017192 |
| Link to this page | http://www.wikipatents.com/4017192.html |
| Inventor(s) | Rosenthal; Robert D. (Gaithersburg, MD) |
| Abstract | A technique for automatic detection of abnormalities, particularly
pathology, in biomedical specimens. Light transmittance or reflectance
data over a large number of wavelengths for numerous samples are
correlated mathematically with conventional clinical results to select
test wavelengths and constants for a correlation equation. Optical
instrumentation with an analog or digital computer applies the resulting
correlation equation to the spectral data on a given specimen at the test
wavelengths to determine quantitatively the presence of the abnormality. |
| |
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 4017192 |
|
|
Optical analysis of biomedical specimens |
|
|
|
|
|
| Publication Date |
April 12, 1977 |
|
|
|
|
|
| Filing Date |
February 6, 1975 |
|
|
|
|
|
|
|
|
|
|
|
| Parent Case |
CROSS-REFERENCE TO RELATED APPLICATIONS
The subject matter of this application is related to that of U.S. Pat. No.
3,765,775 to Eugene R. Gannssle and Donald R. Webster, issued Oct. 16,
l973 entitled "Optical Quality Analyzer", U.S. Pat. No. 3,861,788 issued
Jan. 21, l975 to Donald R. Webster entitled "Optical Analyzer for
Agricultural Products", and U.S. patent application, Ser. No. 283,270,
filed Aug. 24, l972 by Donald R. Webster, assigned to the assignee of this
application. U.S. Pat. No. 3,861,788 in its entirety is incorporated
herein by reference.
BACKGROUND OF THE INVENTION
The invention relates generally to the field of biomedical pathology and
instruments for measuring and analyzing the optical properties of organic
materials.
In the past, abnormalities in biomedical cellular material, for example
malignant cells in a cervical biopsy, have had to be subjected to
microscopic investigation by laboratory technicians specially trained in
pathology. The use of qualitative visible and near-infrared
spectrophotometry is, however, well established in the clinical laboratory
for certain kinds of tests. Nevertheless, the use of spectral absorption
techniques for quantitative analysis has had little, if any, clinical
application.
U.S. Pat. No. 3,861,788 describes an optical analyzer designed to obtain
reflectivity data from agricultural specimens such as grain and to
determine the percent of various constitutents, particularly protein,
water and oil by means of analog computation of the values of linear
functions of the variables .DELTA.OD, the difference in optical density at
several characteristic wavelength pairs.
Cancer of the uterus is the number one killer of women in the U.S.. Pap
smears and cervical scrapings provide tissue specimens which are analyzed
in the laboratory to diagnose uterine cancer. Only a small percentage of
the nation's women have pap smears or scrapings taken regularly. If every
woman in the U.S. had a pap smear taken and analyzed once a year, the
death rate from uterine cancer would be drastically reduced because it is
susceptible to early treatment. However, because pap smears and cervical
scrapings require tedious microscopic analysis by trained laboratory
technicians, there is no way that pap smears from every woman in the
United States just once a year could ever be analyzed, given the limited
availability of laboratory technicians and facilities. Hence, the interest
in developing an instrument which will automatically, instantaneously
diagnose cancerous biopsies is grounded in the realization that this is
the only way that an effective nationwide program of uterine cancer
detection can be carried out at all. No previous systems are adequate to
this challenge.
SUMMARY OF THE INVENTION
In a technique for automatic detection of abnormalities, particularly
pathology, in biomedical specimens, light transmittance or reflectance
data over a large number of wavelengths for numerous samples are
correlated, for example by multiple linear regression analysis, with
conventional clinical results to select test wavelengths and constants for
a correlation equation. Optical instrumentation with an analog or digital
computer applies the resulting correlation equation to the spectral data
on a given specimen at the test wavelengths determine quantitatively the
presence of the abnormality. Specific examples are given for cervical
cancer, cancer in mice and rats, and contaminated serum. In one form of
instrumentation, an automatic monochromator, in the form of a rotatable
paddlewheel of filters, illuminates the specimen with progressively
shifting narrow band radiation. The output of a photodetector, positioned
to receive light transmitted through the specimen, is sampled to yield
values indicative of transmissivity at the test wavelengths. In one
embodiment, these values are converted to optical density and a plurality
of stored optical density values at different wavelengths are manipulated
by an analog computer programmed to perform a linear calculation. In
another embodiment, the output of the photodetector is converted to
digital form and fed to a digital computer adapted to store a plurality of
values about each test wavelength and to perform a programmed sequence of
operations to produce values at each test wavelength of the ratio of a
derivative of transmissivity of the specimen to absolute transmissivity.
The value of a linear function of these ratios indicates a specific
abnormality. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
Description  |
|
|
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a block and schematic diagram illustrating apparatus for carrying
out one of the techniques of the invention;
FIG. 2 is a block and schematic diagram for carrying out another of the
techniques of the invention;
FIG. 3 is a typical graph of optical density versus wavelength for rat
livers with and without cancer;
FIG. 4 is a line-plot of x-values of the correlation equation for rat liver
cancer;
FIG. 5 is a typical graph of optical density versus wavelength for mice
with and without cancer;
FIG. 6 is a line-plot of x-values of the correlation equation for cancerous
mice;
FIG. 7 is a typical graph of optical density versus wavelength for
contaminated and control serum; and
FIG. 8 is a typical graph of dT/T versus wavelength for a nonmalignant
cervical scraping.
DETAILED DESCRIPTION
The optical instrumentation 10 in FIGS. 1 and 2 includes an infrared lamp
12 which directs wideband light through a lens 14 to illuminate a focused
area on a sample drawer 16. The drawer 16 is adapted to carry a specimen
18 which may be in liquid, solid or gaseous form. The sample drawer 16
should be apertured so as to present no obstacle but the specimen to light
above and below the focused area. A multiple filter assembly 20 in the
form of a paddlewheel is mounted for rotation about an axis a
perpendicular to and spaced from the light path defined between the lamp
12 and the illuminated area on the sample drawer 16. The paddlewheel is
typically driven at about 600r.p.m. In the preferred embodiment, three
narrow bandwidth plate-shaped optical interference filters 22 are mounted
on a hexagonal axle 24. The respective planes of the filters 22 are
equally separated angularly by about 120.degree.. The filter extend
radially from the axle in planes which intersect approximately in a line
conincident with the axis of rotation a. The filters 22 extend equal
radial distances from the axis a. The configuration of the filters 22 on
the axle 40 thus resembles the letter .UPSILON.in cross-section. Opaque
vanes can be attached to the ends of the filter to intermittently abstruct
the light path.
In FIG. 1, the pulse point output 26 of the paddlewheel is passed through a
counter circuit 30 which can be set as discussed in U.S. Pat. No.
3,861,788 to provide individual control signals corresponding to selected
angles in the rotation of the paddlewheel and thus to specific wavelengths
of interest. The output of the photodetector 28 is passed to a low noise
sensor amplifier 32, which is implemented as shown in U.S. Pat. No.
3,861,788. The output of the sensor amplifier 32 is fed via a logarhythmic
amplifier 34 to four sample and hold circuits 36, 38, 40 and 42 gated
respectively by four outputs of the settable counter circuit 30. Each
sample and hold circuit is gated to store a value of optical density at a
selected wavelength. An analog computer 43 receives the output of the
sample and hold circuits 36, 38, 40 and 42 to multiply the individual
optical densities by constants and to sum the resulting products according
to a programmed expression. The value of the resulting expression relative
to a predetermined level is related to a property of the specimen.
If linear expressions involving .DELTA.OD instead of OD were desired, for
example, for eight wavelengths, the number of sample and hold circuits
could be doubled or the arrangement using a differential amplifier and two
stages of sample and hold circuitry could be used as shown in U.S. Pat.
No. 3,861,788.
In FIG. 2, the output of the low noise sensor amplifier 32 receiving the
photodetector output 28, instead of going to the subsequent analog
circuitry in FIG. 1, is fed to analog to digital converter 44. The
multibit digital output of the converter 44, representative of
transmissivity at the various wavelengths passed by the paddlewheel 20 is
fed to the parallel data input of a digital computer 46. The data input of
the digital computer 46 is gated by means of the pulse point output 26
which acts as a clock signal. The circuitry in FIG. 2 is inherently
superior to that in FIG. 1 for one primary reason: storage capacity.
If the output of the sensor amplifier is digitally encoded into 12 parallel
bit channels, and of the 1,000 pulse points per revolution, there are only
100 nonredundant useful points per filter for a total of 300 pulse points
which correspond to wavelengths, the amount of digital memory necessary to
store values of transmissivity for every one of the 300 wavelengths is
only 300 .times. 12 = 3,600 bits. To store 300 more points for absolute
transmissivity without the specimen, the storage capacity should be
doubled to 7200 bits. In comparison, the equivalent of the simultaneous
storage capacity of the analog equipment in FIG. 1 is only 48 bits. Of
course, with the digital embodiment of FIG. 2 in a commercially practical
system, one would provide only as much storage as needed and program the
input to the digital computer 46 to transfer the output of the converter
44 to memory only for selected pulse points. For example, if only 80 pulse
points were needed for computations involving absolute and specimen
transmissivity, the amount of storage would be 12 .times. 2 .times. 80 =
1920 bits.
The digital computer 46 should be one programmed or programmable to carry
out specified arithmetic operations using the stored values of
transmissivity as well as a plurality of constant factors which are fed
into the computer to carry out a particular formula.
Transmissivity, T, is defined as ratio of the intensity of transmitted
light, I.sub.t to the intensity of incident light, I.sub.i at a given
wavelength. Absolute transmissivity, T.sub.abs is defined as the intensity
of light transmitted to the photodetector in the absence of a specimen at
a given wavelength.
If the test calls for a reflectance measurement rather than transmittance,
one or more photodetectors can be arranged above the sample drawer 16 to
receive light reflected from the specimen, as shown in FIG, 1 of U.S. Pat.
No. 3,861,788.
Optical density at a given wavelength, e.g., 1935 A and the difference
between optical densities at two different wavelengths, e.g., 1935 A and
1680 A are defined as follows:
Ti, od.sub.1935 = log (1/t.sub.1935),
where, TI, T.sub.1935 = (I.sub.t /I.sub.i).sub.1935;
thus, TI, OD.sub.1935 - OD.sub.1680 = .DELTA. OD = Log (T.sub.1680
/T.sub.1935) = Log (I.sub.tl680 /I.sub.t1935).
If one is analyzing water alone with a substance of constant
transmissivity, the value of .DELTA.OD at the wavelengths in the
expression above can be used in the following linear expression to arrive
at a moisture percentage measurement:
Ti, % h.sub.2 0 = k.sub.O + k.sub.1 .DELTA.OD,
where k.sub.0 and k.sub.1 are constants.
As discussed in U.S. Pat. No. 3,861,788 where the specimen contains not
just water but other substances of varying transmittance, including for
example, protein and oil, the simple expression using one value of
.DELTA.OD is inaccurate. Each of the substances in the specimen has its
own spectral absorption curve and thus the overall transmissivity of any
given wavelength is affected by the spectral absorption curve of each
substance in the specimen. Thus, it has been found that by using
characteristic .DELTA.OD'for the spectral absorption curve associated with
each substance of primary interest in the expression for just one
substance, the results obtained through use of these
percentage-determining equations can be correlated more closely with
analytical results. For example, as discussed in U.S. Pat., 3,861,788, for
agricultural products a more useful expression for moisture percentage is
k.sub.0 = k.sub.1 (.DELTA.OD.sub.w) = k.sub.2 (.DELTA.OD.sub.O) = k.sub.3
(.DELTA.OD.sub.p), where, w, 0 and p refer to the characteristic
wavelength pairs for water, oil and protein, respectively, at which
optical densities are measured and their respective differences obtained.
The following examples illustrate new biomedical applications of spectral
transissivity correlation. In each of these tests the basic parameters
were chosen, either optical density or the value of dT/T at a particular
wavelength, and the values of the parameters for a plurality of sample
specimens under observation were recorded for different wavelengths in a
computer memory. After the tests were complete, each specimen was analyzed
by conventional laboratory techniques to determine whether or not the
specimens had a given abnormality such as malignancy. In the case of the
fourth example, using cervical cancer, "maybe"was thrown in as a third
level variable. Next the affirmative or negative results of the laboratory
tests on each individual sample were entered into a computer for
correlation analysis with, for instance 300 values of OD stored for each
sample. Next came a correlation analysis which is a conventional technique
for arriving at an expression involving a mathematical function of the
spectral data for any specimen such that the respective values of that
expression for all specimens which are affirmative (e.g., malignant) are
higher than the respective values of that expression for all specimens
which are negative according to the laboratory results. There are many
known techniques for correlating two sets of data like the spectral and
laboratory data. In all of the examples which follow, except experiment
No. 1the type of correlation used to arrive at the expression known as a
correlation equation is multiple linear regression analysis assuming a
Gaussian distribution of samples even though the pathology information was
only in the form of affirmative and negative conclusions. That is no
"degree"or "level"of cancer was stated. It is recognized that a Gaussian
assumption is not valid for simple binary data. Nevertheless, this
approach appears to work well for selecting the optimum absorption
wavelengths as evidenced by the data below.
It is important to recognize that the type of computer on which this
correlation analysis is performed is not the type shown in either FIG. 1
or FIG. 2. The apparatus shown in the FIGS. relates to special purpose
instrumentation which uses the correlation equation arrived at by means of
multiple linear regression analysis performed on another computer with
much greater capacity and flexibility.
The following four experiments were run to determine whether useful
correlation equations could be produced just for the sample specimens. The
subjects of the test were are follows: (1) six rats, some with cancer of
the liver; (2) 22mice, some with cancer of the bladder; (3) 20 vials of
25% normal human serum albumin, some with microorganisms; and (4) 22
cervical scrapings, some with malignancy, some without and some
questionable. In the first three experiments, the test parameter was OD.
That is, optical instrumentation like that shown at 10 in FIGS. 1 and 2
was used to produce a photodetector output to a sensor amplifier whose
output was fed to a logarithmic amplifier before being fed to a digital
computer. The fourth test on cervical scrapings used the parameter
dT/T.sub.abs. This term is the ratio of the derivative of transmissivity
of the specimen at a given wavelength to the absolute transmissivity
without the specimen at that wavelength. The parameter dT/T.sub.abs is
more sensitive than the parameter OD and thus one could expect an
improvement in the correlation between the spectral and laboratory data in
the first three tests if the parameter dT/T.sub.abs was used instead of
OD. The parameter d.sup.2 T/T, that is the second derivative of the
specimen transimissivity over the absolute transmissivity, may produce
even greater correlation although it is more difficult to instrument. The
OD correlation equations generated for the first three experiments could
be implemented as shown in FIG. 1. The additional mathematical complexity
of the dT/T computation in experiment No. 4 makes analog equipment
impractical and necessitates digital instrumentation as shown in FIG. 2.
__________________________________________________________________________
Experiment No. 1
__________________________________________________________________________
Test subjects: six one-year old male Holzman rats
Abnormality: about half expected to have liver
cancer induced by carcinogen
pesticide in feed (400 ppm
2 acetyl amino flourene)
Optical Instrumentation
Type of illuminator:
Cary-14 monochromator
Spectrum: 5000 - 10,000 A
Type of photodetector:
Solid state silicon
Maximum OD: 5.0
Specimens: surgically removed rat livers
Laboratory Analysis:
microscopic pathological examination
of each liver after taking spectral
data
Typical rat liver spectrum:
see FIG. 3 (OD vs. .lambda.)
Correlation Wavelengths:
Primary pair:
1 -9575 A
2 -1832 A
(see arrows in FIG. 3)
Correlation equation:
X = 17.9 + 69.1 OD.sub.1 - 53.4 OD.sub.2,
where 1 and 2 refer to the wave-
lengths above
X-Distribution: see FIG. 4
__________________________________________________________________________
A comparison of the correlation equation results with those of simple
observation is presented in Table 1 below, where N and C mean normal and
cancerous, respectively:
TABLE I
______________________________________
RAT LIVER
NUMBER 1 2 3 4 5 6
______________________________________
PATHOLOGY
RESULTS N C C N C C
VISUAL
JUDGEMENT N C C N C N
CORRELATION
EQUATION N C C N C N
______________________________________
Like FIG. 3, the above table indicates that all samples were correctly
predicated except for rat liver No. 6. Because there were only six
samples, only a primary pair of wavelengths were found. Thus, the above
correlation could not take advantage of multiple linear regression of
wavelength pairs. It was noted for these rats that the cancerous livers
had higher optical absorptions than the normal ones, probably because the
tumor had a different refractive index than the liver and thus increased
the scattering of light.
__________________________________________________________________________
Experiment No. 2
__________________________________________________________________________
Test Subjects: 22 female bulb/c-breed mice
Abnormality: about half expected to have bladder
cancer induced by carcinogen
pesticide in feed (50-250 ppm
2 acetyl amino flourene)
Optical Instrumentation:
same as in Experiment No. 1
Specimens: whole mice (bladder in vivo)
attached in a spreadcalf position
to a square metal frame with
ventral side facing illuminator
Laboratory Analysis:
surgical removal and microscopic
pathological examination of each
bladder after taking spectral data
Typical Mouse Spectrum:
see FIG. 5 (OD vs..lambda.)
Correlation Wavelengths:
Primary Pair:
No. 1 5900 A
No. 2 8600 A
Secondary Pair:
No. 3 8200 A
No. 4 10620 A
Correlation Equation:
X = 239.1 - [57.2 OD.sub.1 - 54.2 OD.sub.2] -
[42.3 OD.sub.3 + 16.0 OD.sub.4]
X-Distribution: see FIG. 6
__________________________________________________________________________
It was possible to do the mice tests in vivo because the transmittance
typically produced optical densities below 5.0 OD. Each mouse was
anesthetized with ethyl ether and then its feet were tied to the corners
of the rectangular frame. The animal was positioned so that the collimated
monochromator beam, approximately 5 millimeters in size, intersected the
bladder region. The optical energy impacting the mouse was measurable in
milliwatts.
The large difference in absorption between 5900 A and about 10,000 A in
FIG. 5 was a characteristic separation between malignant and nonmalignant
for almost all mice tested. In fact, prior to receiving the pathology
results, a "blind test" was performed using all the spectrum traces. This
was done by sorting all the spectrum curves into two groups: those with
high absorption between 5900 A and 10,000 A, and those with lower
absorption. This simple visual judgement proved correct on 20 of the 22
mice; the only "error" was for malignant mice 11 and 12. The results of
this visual examination of the spectrum traces is summarized in the
"visual" column of TAble II below:
TABLE II
__________________________________________________________________________
MOUSE
NUMBERS 1 2 3 4 5 6 7 8 9 10
11
12
13 14 15 16 17 18 19
20
21
22
__________________________________________________________________________
PATHOLOGY
RESULTS N N N N N N N N N N C C C C C C C C C
C
C
C
VISUAL
JUDGMENT N N N N N N N N N N N N C C C C C C C
C
C
C
CORRELATION
EQUATION N N N N N N N N N N C C C C C C C C C
C
C
C
__________________________________________________________________________
In this experiment, the larger number of test specimens enabled use of two
pairs of wavelengths in multiple linear regression analysis to correlate
the spectral and pathological data.
The mice and rat data raises the following questions:
1. Is the correlation really relating the spectrum data to the presence of
malignancy? Or could it be that the spectrum correlation is actually
relating the presence of the pesticide residue that was in the diet of the
cancerous mice and rats, or perhaps some side effect due to the pesticide
2. It is usually expected that the presence of an additional layer of
material --i.e., malignant cells on the gladder --would cause an increase
in "light scattering" because of the cahnge in refractive index. An
increase in light scattering should cause the optical density to increase.
Yet the spectrum traces for the cancerous mice show a decrease in optical
density with the presence of a tumor.
______________________________________
Experiment No. 3
______________________________________
Test Subjects: 20 50cc glass vials of 25% human
serum albumin selected from four
different production lots to include
any effect of typical color
variation (see Table III below)
Abnormality: 80% deliberately contaminated with
microorganisms as indicated in
Table III; no apparent difference
in turbidity (i.e., cloudiness)
between control and contaminated
samples
Optical Instrumentation:
same as in Experiment No. 1
Specimens: each sample was analyzed without
removal from the vial; light beam
intersected cylindrical axis of
vial at right angles
Laboratory analysis:
concentration of microorganism
known beforehand
Typical albumin spectrum:
see FIG. 7 (OD vs. .lambda.)
Correlation Wavelengths:
Primary Pair:
No. 1 -5034 A
No. 2 -5374 A
Secondary Pair:
No. 3 -6258 A
No. 4 -5731 A
Correlation Equation:
X=9.41+[64.4 OD.sub.1-251.1 OD.sub.2]-
[86.2 OD.sub.3-273.6 OD.sub.4]
______________________________________
Experiment No. 3 demonstrates that light transmission can be used as a high
speed sorting means of separating contaminated vials on the production
line.
Control and contaminated samples are arbitrarily given the nominal values
one and ten respectively. In Table III below, the "computed" column
represents the value, X, of the correlation expression for the given
sample. The "difference" column indicates how close the computed value
came to the nominal value. There is a clear separation (screening limit)
between the control versus the contaminated samples; the highest computed
X-value for a control sample is 5.996 and the lowest for the contaminated
samples is 6.310. This separation appears to be statistically significant.
TABLE III
__________________________________________________________________________
VIAL IDENTIFICATION
TYPE
NUMBER
CODE* BACTERIA
BACTERIA CONCENTRATION
__________________________________________________________________________
1 1 - 0 Control None
2 2 - 0 Control None
3 3 - 0 Control None
4 4 - 0 Control None
5 1 - 1 P. aeroguosa
6.0 .times. 10.sup.6 ORG/ML
6 2 - 1 P. aeroguosa
6.0 .times. 10.sup.6 ORG/ML
7 3 - 1 P. aeroguosa
6.25 .times. 10.sup.6 ORG/ML
8 4 - 1 P. aeroguosa
4.7 .times. 10.sup.6 ORG/ML
9 1 - 3 S. aureus
3.6 .times. 10.sup.7 ORG/ML
10 2 - 3 S. aureus
1.25 .times. 10.sup.7 ORG/ML
11 3 - 3 S. aureus
5.35 .times. 10.sup.6 ORG/ML
12 4 - 3 S. aureus
9.0 .times. 10.sup.6 ORG/ML
13 1 - 5 Bacillus sp.
1.0 .times. 10.sup.6 ORG/ML
14 2 - 5 Bacillus sp.
9.8 .times. 10.sup.5 ORG/ML
15 3 - 5 Bacillus sp.
8.7 .times. 10.sup.5 ORG/ML
16 4 - 5 Bacillus sp.
1.17 .times. 10.sup.6 ORG/ML
17 1 - 7 Unidentified (-)
5.7.times. 10.sup.6 ORG/ML
18 2 - 7 Unidentified (-)
4.6 .times. 10.sup.5 ORG/ML
19 3 - 7 Unidentified (-)
2.8 .times. 10.sup.5 ORG/ML
20 4 - 7 Grain - bacilli
1.8 .times. 10.sup.6 ORG/ML
__________________________________________________________________________
VIAL X-VALUE
NUMBER
COMPUTED NOMINAL
DIFFERENCE
__________________________________________________________________________
1 2.163 Control 1.000 1.163
2 5.299 1.000 4.299
3 5.996 1.000 4.996
##STR1##
##STR2##
##STR3##
##STR4##
##STR5##
__________________________________________________________________________
* first digit is lot number
______________________________________
Experiment No. 4
______________________________________
Test Subjects: 22 human cervical scrapings
Abnormality: 4 samples malignant; 6 others had
atypical cells
Optical Instrumentation:
same as at 10 in FIGS. 1 and 2
Type of Illuminator:
paddlewheel 20
Spectrum: 1600 nm to 2350 nm
Type of Photodetector:
solid state silicon
Maximum OD: 5.0
Specimen: scrapings suspended in 2.5 ml, 50%
ethyl alcohol, 50% distilled water
in optically flat bottom cup
(equivalent thickness of the
solution was 1.5 mm).
Laboratory Analysis:
conventional diagnostic cytology
prior to taking spectral data
Typical Cervical Scraping
Spectrum: see FIG. 8 (dT/T.sub.abs vs. .lambda.)
Correlation Wavelengths
Using 22 Samples to
Compute 5 Constants:
Primary Pair:
No. 1
No. 2
Secondary Pair:
No. 3
No. 4
Corresponding Correlation
Equation: X.sub.1 = 9.998 - 16140 (dT/T)
-10190 (dT/T).sub.2 + 5624 (dT/T).sub.3
-6580 (dT/T).sub.4
Correlation Wavelengths
Using 16 Samples
(Without Nos. 14, 15,
16, 18, 20, 21): Primary Pair
No. 1
No. 2
Secondary Pair
No. 3
No. 4
Corresponding Correlation
Equation: X.sub.2 = 9.349 - 25780(dT/T).sub.1
- 9242(dT/T).sub. 2 + 26800(dT/T).sub. 3 -
7920(dT/T).sub. 4
______________________________________
Experiment No. 4 demonstrates the potential of light transmittance analysis
as a rapid screening method for cervical cytology samples used in the
detection of uterine cancer. The previously studied samples were assigned
nominal values of 1,6 and 10 to indicate, respectively, that they were
malignant, questionable or nonmalignant. These laboratory values were then
correlated with the spectral data for dT/T.sub.abs by multiple linear
regression analysis assuming Gaussian distribution even though the sample
population was not necessarily normal. On the computer, the dT/T values
are produced by plotting all 300 values of transmittance, T, developing an
equation to fit the plotted curve, taking the first derivative of the
equation, and computing the value of all dT/T.sub.abs over all 300
discrete wavelengths. As discussed below, this procedure differs from a
practical instrumentation approach to deriving the values of dT/T.sub.abs,
for instance, at four different wavelengths.
The term dT/T was chosen over OD because it produces more sensitive low
noise data analysis. A second derivative term d.sup.2 T/T.sub.abs could
also be used for this purpose.
Table IV below summarizes the results of the correlations using the X.sub.1
and X.sub.2 correlation equations.
TABLE IV
__________________________________________________________________________
Equation No. 1
Equation No.
__________________________________________________________________________
2
Malignancy
__________________________________________________________________________
Sample X-Value X-Value
Number
Classification Patient History
Nominal
Computed
Difference
Computed
Difference
__________________________________________________________________________
1 Cervicitis None 10.00
10.54 0.5427
9.243 -0.7569
2 Cervicitis None 10.00
8.928 -1.072
9.921 -.07321
3 Cervicitis-Trichomonas
None 10.00
10.28 0.2780
6.965 -1.835
4 Cervicitis None 10.00
8.925 -1.075
9.352 -0.6421
5 Normal None 10.00
10.77 0.7717
12.37 2.374
6 Cervicitis-Trichomonas
None 10.00
9.842 -0.1585
6.937 -3.063
7 Cervicitis-Trichomonas
None 10.00
9.164 -0.8356
10.42 0.4213
8 Cervicitis-Trichomonas
None 10.00
7.421 -2.576
11.76 1.761
9 Cervicitis None 10.00
9.123 -0.8769
6.583 -3.417
10 Cervicitis-Trichomonas
None 10.00
8.618 -1.382
8.339 -1.661
11 Squamous cell carcinoma
Untreated invasive
1.000
4.734 3.734 3.317 2.317
squamous cell
carcinoma
12 Uterina sarcoma 1.000
3.628 3.620 2.008 1.808
13 Normal Adenocarcinoma,
10.00
3.820 -6.180
5.453 4.547
endometrium
14 Atypical eithelial cells
Radiation therapy
6.000
7.443 1.443
for Squamous cell
carcinoma
15 Atypical epithelial cells
Radiation therapy
6.000
7.439 1.439
for squamous cell
carcinoma
16 Atypical epithelial cells
Radiation therapy
6.000
3.442 -2.588
for squamous cell
carcinoma
17 Inflammation ? malignancy 10.00
8.154 -1.846
9.977 .02259
Atypical epithelial cells
Radiation therapy
6.000
8.453 2.453
for squamous cell
carcinoma
19 Squamous cell carcinoma,
Untreated squamous
1.000
4.740 3.740 6.568 5.568
cervix cell carcinoma
20
Very bloody -
? malignancy 6.000 5.425
-0.5738
endometrial cells present
21 Atypical epithelial cells
Vulvectomy for
6.000
7.748 1.748
squamous cell
carcinoma, vulva
22 Squamous cel | | |